Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus metoprolol for reducing bleeding during craniotomy after head trauma
IRCT20190417043302N1Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in traumatic brain injury (TBI) comparing Dexmedetomidine, Metoprolol and Placebo control (3 arms). Primary endpoints: Intraoperative bleeding and Mortality. Started May 2018; status: completed.
02
Drugs
dexmedetomidinemetoprolol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20190417043302N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190417043302N1.